Telemedicine for Postpartum Complications
(IMPACT Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to compare two complex, multi-component evidence-based postpartum interventions in underserved populations of lower socioeconomic status in an effort to reduce maternal morbidity and mortality.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Enhanced Virtual Care, Telehealth, Remote Care, Virtual Health Services, Intensive Education, Problem-Solving Education, Postpartum Education for postpartum complications?
Research shows that telemedicine, including remote monitoring and education, can improve health outcomes and access to care. For example, telehealth has been effective in managing postpartum hypertension and diabetes, reducing hospital visits, and increasing patient satisfaction. Additionally, educational programs have been shown to enhance healthcare practices and patient care.12345
Is telemedicine safe for postpartum care?
How is the treatment 'Enhanced Virtual Care, Intensive Education' for postpartum complications different from other treatments?
This treatment is unique because it uses telemedicine (remote healthcare services) to provide enhanced virtual care and intensive education for postpartum complications, allowing for personalized and timely support without the need for in-person visits, which is particularly beneficial during times like the COVID-19 pandemic.110111213
Research Team
Elaine Duryea, MD
Principal Investigator
UT Southwestern Medical Center
David B Nelson, MD
Principal Investigator
UT Southwestern Medical Center
Eligibility Criteria
This trial is for postpartum women who gave birth to a live infant at Parkland Hospital or Grady Health and are getting care at certain community clinics. They must be 18 or older and able to give informed consent. Women who didn't deliver at these hospitals or don't speak English or Spanish can't join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Phase 1 - Baseline Data Collection
Collection of baseline data and ensuring patient input into the final study design
Phase 2 - Randomization and Intervention
Participants are randomized into either the enhanced virtual care model or the intensive education care model
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of mental health, emergency room visits, and long-term disease control
Treatment Details
Interventions
- Enhanced Virtual Care (Behavioural Intervention)
- Intensive Education (Behavioural Intervention)
Enhanced Virtual Care is already approved in Canada for the following indications:
- Primary care
- Specialty care
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor
Daniel K. Podolsky
University of Texas Southwestern Medical Center
Chief Executive Officer since 2008
MD from Harvard Medical School
Robert L. Bass
University of Texas Southwestern Medical Center
Chief Medical Officer since 2019
MD from University of Texas Southwestern Medical School
Patient-Centered Outcomes Research Institute
Collaborator
Nakela L. Cook
Patient-Centered Outcomes Research Institute
Chief Executive Officer since 2020
MD, MPH
Harv Feldman
Patient-Centered Outcomes Research Institute
Chief Medical Officer
MD, MSCE